There are 413 resources available
No
Presenter: Joana Ribeiro
Session: Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Peter Dubsky
Session: Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions
Resources:
Slides
Webcast
Case 1: Detection of treatment toxicity through remote monitoring
Presenter: Martina Pagliuca
Session: YO Clinical case discussion
Resources:
Slides
Webcast
Recent progresses on the treatment of luminal metastatic breast cancer with CDK 4/6 inhibitors
Presenter: Gustavo Werutsky
Session: Optimal sequencing in advanced luminal breast cancer
Resources:
Slides
Webcast
193MO - Development of a Deep Learning model using a large real-world database to predict overall survival in patients with metastatic breast cancer (MBC)
Presenter: Laura Vuduc
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Emerging data on oral selective estrogen receptor degraders
Presenter: Sara Hurvitz
Session: Optimal sequencing in advanced luminal breast cancer
Resources:
Slides
Webcast
Mentor guided discussion
Presenter: Nadia Harbeck
Session: YO Clinical case discussion
Resources:
Webcast
3MO - HER2 expression and early response to patritumab deruxtecan (HER3-DXd) in early-stage hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC): a correlative analysis from SOLTI-TOT-HER3 trial
Presenter: Fara Brasó-Maristany
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Case 2: Triple-negative early breast cancer in monozygotic twins
Presenter: Marta Perachino
Session: YO Clinical case discussion
Resources:
Slides
Webcast
New insights on endocrine therapy resistance in luminal metastatic breast cancer
Presenter: Monica Arnedos
Session: Optimal sequencing in advanced luminal breast cancer
Resources:
Slides
Webcast